MobioSense focuses on fast-diagnosis platform and reagent development since founded in 2015, and successfully developed testing of COIVD-19 and African swine fever(ASFV) by using Isothermal nucleic acid amplification assay.
Our COVID-19 nucleic acid testing reagent has already certified by Taiwan FDA, is the first and only company in Taiwan, which develops Isothermal nucleic acid amplification assay under in-vitro diagnostic (IVD) regulation.
MOBIOSENSE IS ONE OF THE STORMERS OF PRIVATE VIRTUAL BUSINESS LAUNCHPAD
IN COLLABORATION WITH IAPS
Virtual Business Launchpad (VBL) is a programme whereby entrepreneurs from multiple verticals and countries come together to spark invaluable ideas and build long-term relationships to help them accelerate their growth.